The Influence of Family History on Stage and Survival of Gastric Cancer According to the TGFB1 C-509T Polymorphism in Korea
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: The survival rate of gastric cancer (GC) is known to be higher in patients with a family history (FH) of GC. There is an association between a polymorphism in the transforming growth factor-β1 (TGFB1) gene and the risk of GC in patients with first-degree relatives with GC. This study was performed to investigate whether a FH affects GC outcomes according to the TGFB1 C-509T polymorphism. Methods: TGFB1 was genotyped by the polymerase chain reaction-restriction fragment length polymorphism method in 1,143 GC patients, including 216 patients (18.9%) with first-degree relatives with GC. Results: The proportion of stage I-II GCs was significantly higher in patients with a FH than in those without a FH of GC (83.8 vs 74.9%, p=0.005). The association between a FH of GC and stage I-II GC was not significant in subgroups divided based on the TGFB1 C-509T polymorphism and sex. A FH did not affect the overall survival rate of GC in patient with all stages and each stage. The overall survival rates were not significantly different between patients with the CC and CT/TT genotypes of the TGFB1-509 polymorphism. Conclusions: Patient with a FH of GC had lower cancer stage (I-II) at diagnosis than those without a FH of GC, but there was no significant difference in overall survival between the patients with and without a FH of GC. A FH did not influence the tumor stage or overall survival in patients stratified by the presence of the TGFB1 C-509T polymorphism.
Abstract
Background/Aims: The survival rate of gastric cancer (GC) is known to be higher in patients with a family history (FH) of GC. There is an association between a polymorphism in the transforming growth factor-β1 (TGFB1) gene and the risk of GC in patients with first-degree relatives with GC. This study was performed to investigate whether a FH affects GC outcomes according to the TGFB1 C-509T polymorphism. Methods: TGFB1 was genotyped by the polymerase chain reaction-restriction fragment length polymorphism method in 1,143 GC patients, including 216 patients (18.9%) with first-degree relatives with GC. Results: The proportion of stage I-II GCs was significantly higher in patients with a FH than in those without a FH of GC (83.8 vs 74.9%, p=0.005). The association between a FH of GC and stage I-II GC was not significant in subgroups divided based on the TGFB1 C-509T polymorphism and sex. A FH did not affect the overall survival rate of GC in patient with all stages and each stage. The overall survival rates were not significantly different between patients with the CC and CT/TT genotypes of the TGFB1-509 polymorphism. Conclusions: Patient with a FH of GC had lower cancer stage (I-II) at diagnosis than those without a FH of GC, but there was no significant difference in overall survival between the patients with and without a FH of GC. A FH did not influence the tumor stage or overall survival in patients stratified by the presence of the TGFB1 C-509T polymorphism.
참고문헌 (41)
- Global Burden of Disease Cancer Collaboration, "Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015 : a systematic analysis for the Global Burden of Disease Study", JAMA Oncol, 3, pp.524~548 (2017)
- Chiba T, "Mechanism for gastric cancer development by Helicobacter pylori infection", J Gastroenterol Hepatol, 23(8 Pt 1), pp.1175~1181 (2008)
- Wu AH, "A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus(United States)", Cancer Causes Control, 12, pp.721~732 (2001)
- Uemura N, "Helicobacter pylori infection and the development of gastric cancer", N Engl J Med, 345, pp.784~789 (2001)
- Rivas-Ortiz CI, "Genetic alterations in gastric cancer associated with Helicobacter pylori infection", Front Med(Lausanne), 4, pp.47~ (2017)
- Yaghoobi M, "Family history and the risk of gastric cancer", Br J Cancer, 102, pp.237~242 (2010)
- Oliveira C, "Familial gastric cancer : genetic susceptibility, pathology, and implications for management", Lancet Oncol, 16, pp.e60~e70 (2015)
- Han MA, "Association of family history with cancer recurrence and survival in patients with gastric cancer", J Clin Oncol, 30, pp.701~708 (2012)
- Bernini M, "Family history of gastric cancer : a correlation between epidemiologic findings and clinical data", Gastric Cancer, 9, pp.9~13 (2006)
- Palli D, "Dietary and familial determinants of 10-year survival among patients with gastric carcinoma", Cancer, 89, pp.1205~1213 (2000)
- Gao Y, "Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China", BMC Cancer, 9, pp.269~ (2009)
- Oh MG, "Family history and survival of patients with gastric cancer : a meta-analysis", Asian Pac J Cancer Prev, 15, pp.3465~3470 (2014)
- Camargo MC, "Sex hormones, hormonal interventions, and gastric cancer risk : a meta-analysis", Cancer Epidemiol Biomarkers Prev, 21, pp.20~38 (2012)
- Elliott RL, "Role of transforming growth factor beta in human cancer", J Clin Oncol, 23, pp.2078~2093 (2005)
- Chang WW, "An updated meta-analysis of transforming growth factor-beta1 gene : three polymorphisms with gastric cancer", Tumour Biol, 35, pp.2837~2844 (2014)
- Choi YJ, "Influence of TGFB1 C-509T polymorphism on gastric cancer risk associated with TGF-beta1 expression in the gastric mucosa", Gastric Cancer, 18, pp.526~537 (2015)
- Li K, "Association of a tgf-b1-509c", t polymorphism with gastric cancer risk : a meta-analysis, 2013, pp.77, 1~8
- Pavithra D, "TGFbeta C-509T, TGFbeta T869C, XRCC1 Arg194Trp, IKBalpha C642T, IL4 C-590T Genetic polymorphisms combined with socio-economic, lifestyle, diet factors and gastric cancer risk : a case control study in South Indian population", Cancer Epidemiol, 53, pp.21~26 (2018)
- Shin CM, "Intrafamilial aggregation of gastric cancer : a comprehensive approach including environmental factors, Helicobacter pylori virulence, and genetic susceptibility", Eur J Gastroenterol Hepatol, 23, pp.411~417 (2011)
- Ebert MP, "Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucosa of first-degree relatives of patients with gastric cancer", Br J Cancer, 82, pp.1795~1800 (2000)
- Kim HW, "Sex disparity in gastric cancer : female sex is a poor prognostic factor for advanced gastric cancer", Ann Surg Oncol, 23, pp.4344~4351 (2016)
- Kim HJ, "Relationship between body mass index and the risk of early gastric cancer and dysplasia regardless of Helicobacter pylori infection", Gastric Cancer, 18, pp.762~773 (2015)
- Freedman ND, "Male predominance of upper gastrointestinal adenocarcinoma cannot be explained by differences in tobacco smoking in men versus women", Eur J Cancer, 46, pp.2473~2478 (2010)
- Lee WJ, "Clinicopathologic characteristics and prognoses of gastric cancer in patients with a positive familial history of cancer", J Clin Gastroenterol, 36, pp.30~33 (2003)
- 정오, "Clinicopathological Features and Survival of Patients with Gastric Cancer with a Family History: a Large Analysis of 2,736 Patients with Gastric Cancer", Journal of Gastric Cancer, 17(2), pp.162~172 (2017), 대한위암학회
- Shu XO, "Genetic polymorphisms in the TGF-beta 1 gene and breast cancer survival : a report from the Shanghai Breast Cancer Study", Cancer Res, 64, pp.836~839 (2004)
- Ewart-Toland A, "A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer", Cancer Epidemiol Biomarkers Prev, 13, pp.759~764 (2004)
- Gulubova M, "Promoter polymorphisms in TGFB1 and IL10 genes influence tumor dendritic cells infiltration, development and prognosis of colorectal cancer", J Gene Med, 20, pp.e3005~ (2018)
- Zhang P, "Association of transforming growth factor-beta 1 polymorphisms with genetic susceptibility to TNM stage I or II gastric cancer", Jpn J Clin Oncol, 38, pp.861~866 (2008)
- Vagenas K, "TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas : correlation with prognostics factors and patient survival", J Surg Res, 139, pp.182~188 (2007)
- Hawinkels LJ, "Tissue level, activation and cellular localisation of TGF-beta1 and association with survival in gastric cancer patients", Br J Cancer, 97, pp.398~404 (2007)
- Park YS, "Prognostic roles of perioperative body mass index and weight loss in the long-term survival of gastric cancer patients", Cancer Epidemiol Biomarkers Prev, 27, pp.955~962 (2018)
- Martelossi Cebinelli GC, "TGF-beta1 functional polymorphisms : a review", Eur Cytokine Netw, 27, pp.81~89 (2016)
- Nie X, "Effects of estrogen on the gastrointestinal tract", dig dis sci, 63, pp.583~596 (2018)
- Jukic Z, "Gender difference in distribution of estrogen and androgen receptors in intestinal-type gastric cancer", Anticancer Res, 37, pp.197~202 (2017)
- Ryu WS, "Expression of estrogen receptors in gastric cancer and their clinical significance", J Surg Oncol, 106, pp.456~461 (2012)
- Wang M, "Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma : correlation with prothymosin alpha and clinicopathological parameters", Eur J Surg Oncol, 33, pp.195~201 (2007)
- Xu CY, "Prognostic role of estrogen receptor alpha and estrogen receptor beta in gastric cancer", Ann Surg Oncol, 17, pp.2503~2509 (2010)
- Kim SE, "Sex-and gender-specific disparities in colorectal cancer risk", World J Gastroenterol, 21, pp.5167~5175 (2015)
- Fang WL, "Molecular and survival differences between familial and sporadic gastric cancers", Biomed Res Int, 2013, pp.396272~ (2013)
- Kerber RA, "Comparison of self-reported and database-linked family history of cancer data in a case-control study", Am J Epidemiol, 146, pp.244~248 (1997)